TRANIMILAST
Trials 17
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 18 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRANIMILAST | ChEMBL registry synonym — accepted as the source's own label CHEMBL3113974 ↗ |
| Known as | CHF 6001 | “Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers.” PMID 30425469 ↗ Oct 201819“Evaluating the Impact of Hepatic or Renal Impairment on Tanimilast (CHF6001) Pharmacokinetics: Two Open-Label, Parallel-Group, Single-Center Studies.” PMID 40391696 ↗ May 2025 “The purpose of this study is to evaluate the amount of the study drug, CHF6001, in the blood of adolescent patients with asthma” NCT06900816 ↗ “CHF6001 is a novel inhaled phosphodiesterase-4 inhibitor.” PMID 31399091 ↗ Aug 2019 “CHF6001, an inhaled phosphodiesterase-4 inhibitor” PMID 30425469 ↗ Oct 2018 “28-day Inhaled CHF 6001 DPI (1200 µg Daily)” NCT01730404 ↗ |
| Known as | J3.309.618F | ChEMBL registry synonym — accepted as the source's own label CHEMBL3113974 ↗ |
| Known as | tanimilast | “The purpose of this study is to evaluate the efficacy and safety of CHF6001 (Tanimilast) as add-on to maintenance of inhaled corticosteroids in combination with Long-acting...” NCT06029595 ↗6“The purpose of the study is to evaluate the efficacy and safety of two doses of CHF6001 (Tanimilast), as add-on to maintenance triple therapy in the target patient population.” NCT04636801 ↗ “Tanimilast is an inhaled phosphodiesterase-4 inhibitor in development for chronic obstructive pulmonary disease and asthma.” PMID 40391696 ↗ May 2025 “Tanimilast is an inhaled phosphodiesterase-4 inhibitor in development for chronic obstructive pulmonary disease and asthma.” PMID 40391696 ↗ May 2025 “Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects” NCT04756960 ↗ “Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy” NCT04636814 ↗ “CHF6001 (Tanimilast)” NCT06892756 ↗ |
| Action | Inhibit | “CHF6001, a PDE4 inhibitor” NCT01689571 ↗ |
| Modality | Small molecule | — CHEMBL3113974 ↗ |
| Route | Inhaled | “when given by inhalation” NCT01689571 ↗ |